Current Pathology Foundation Models are unrobust to Medical Center Differences
Edwin D. de Jong, Eric Marcus, Jonas Teuwen

TL;DR
This study evaluates the robustness of current pathology foundation models to variations across medical centers, introducing a new metric called the Robustness Index to quantify the dominance of biological versus confounding features.
Contribution
The paper introduces the Robustness Index to measure model robustness to medical center differences and evaluates ten pathology models, revealing most are heavily influenced by confounding center signatures.
Findings
All models show strong influence of medical center signatures.
Only one model has a robustness index above one, indicating slight dominance of biological features.
Medical center origin is more accurately predicted than tissue source or cancer type.
Abstract
Pathology Foundation Models (FMs) hold great promise for healthcare. Before they can be used in clinical practice, it is essential to ensure they are robust to variations between medical centers. We measure whether pathology FMs focus on biological features like tissue and cancer type, or on the well known confounding medical center signatures introduced by staining procedure and other differences. We introduce the Robustness Index. This novel robustness metric reflects to what degree biological features dominate confounding features. Ten current publicly available pathology FMs are evaluated. We find that all current pathology foundation models evaluated represent the medical center to a strong degree. Significant differences in the robustness index are observed. Only one model so far has a robustness index greater than one, meaning biological features dominate confounding features,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlobal Cancer Incidence and Screening · Economic and Financial Impacts of Cancer · Clinical Laboratory Practices and Quality Control
MethodsFocus
